Dipotassium Glycyrrhizinate - Global Strategic Business Report

The global market for Dipotassium Glycyrrhizinate was estimated at US$39.2 Million in 2024 and is projected to reach US$50.7 Million by 2030, growing at a CAGR of 4.4% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Dipotassium Glycyrrhizinate market.

Global Dipotassium Glycyrrhizinate Market - Key Trends & Drivers Summarized

Why Is Dipotassium Glycyrrhizinate Gaining Momentum in Modern Formulations?

Dipotassium Glycyrrhizinate, a salt derivative of glycyrrhizic acid extracted from licorice root, has become a favored ingredient in the pharmaceutical, cosmetic, and personal care industries due to its exceptional anti-inflammatory, soothing, and skin-conditioning properties. Known for its ability to inhibit tyrosinase activity and reduce melanin formation, it is extensively used in skin-whitening and brightening products, especially in the Asian cosmetics markets, where demand for fairer and even-toned skin remains high. In pharmaceutical applications, its steroid-like anti-inflammatory effects without the adverse side effects of corticosteroids make it highly suitable for use in dermatological formulations to treat conditions such as eczema, psoriasis, and atopic dermatitis. The compound also finds use in oral care products, particularly in toothpaste and mouthwashes, due to its ability to reduce gum inflammation and soothe oral mucosa. In recent years, consumer awareness around clean and plant-based ingredients has further propelled the inclusion of Dipotassium Glycyrrhizinate in “natural” and “green” labeled cosmetic formulations. As regulatory restrictions around synthetic and potentially harmful ingredients tighten globally, formulators are turning to safer, naturally derived bioactives like Dipotassium Glycyrrhizinate. Its compatibility with a wide range of formulation systems and its synergistic action with other actives have only enhanced its desirability among manufacturers across sectors.

How Is the Shift Toward Natural and Functional Ingredients Boosting the Market?

The ongoing shift in consumer preferences toward natural, multifunctional, and mild ingredients has had a profound impact on the market dynamics for Dipotassium Glycyrrhizinate. With growing awareness around the long-term effects of synthetic chemicals and allergens in personal care products, end-users are increasingly opting for gentler alternatives that offer effective results without irritation. Dipotassium Glycyrrhizinate fits perfectly into this narrative, as it not only provides anti-inflammatory benefits but also serves as a humectant, skin-soothing agent, and antioxidant all highly prized in skincare and haircare products. Clean beauty trends, especially in North America and Europe, have elevated the status of licorice-derived compounds as non-toxic yet potent ingredients. Additionally, the surge in demand for multifunctional skincare routines in South Korea and Japan has also played a pivotal role in promoting Dipotassium Glycyrrhizinate as a go-to ingredient. Its use is no longer limited to niche products but extends to mainstream serums, masks, toners, sunscreens, and moisturizers. The ingredient also aligns with the growing need for hypoallergenic and dermatologically tested formulations, making it an essential part of pediatric and sensitive skin products. Even in the realm of men's grooming and wellness cosmetics, its adoption is steadily climbing. Moreover, as climate change and pollution-related skin concerns rise, consumers are seeking ingredients that can mitigate redness, irritation, and sensitivity, further expanding the use-case scenarios for Dipotassium Glycyrrhizinate in contemporary product development.

Why Are Regulatory Approvals and Regional Demand Shaping the Market Landscape Differently?

The market for Dipotassium Glycyrrhizinate is significantly influenced by regional regulatory environments, cultural beauty standards, and industry focus. In Asia-Pacific, particularly Japan, China, and South Korea, its use is deeply entrenched in traditional medicine and cosmetic formulations, giving it a long-standing legacy and consumer acceptance. Regulatory bodies in these regions have established clear guidelines supporting its use in topical applications, thus fostering market maturity. Meanwhile, Europe has seen increasing uptake, especially with the enforcement of cosmetic safety regulations under REACH (Registration, Evaluation, Authorization, and Restriction of Chemicals), which favor bio-based and non-toxic ingredients. Brands that promote dermatologically safe, vegan, and eco-conscious formulations are particularly incorporating Dipotassium Glycyrrhizinate into their products. In North America, the clean beauty movement, coupled with rising cases of skin sensitivity and chronic dermatological conditions, has sparked demand for plant-based anti-irritants, leading to greater inclusion of this licorice-derived compound. Latin America and the Middle East are nascent but growing markets, where increasing disposable income, urbanization, and beauty consciousness are introducing consumers to advanced skincare actives. The pharmaceutical industry in these regions is also expanding its topical product lines using Dipotassium Glycyrrhizinate for its non-steroidal anti-inflammatory potential. However, differences in import regulations, documentation requirements, and cosmetic ingredient registration procedures can act as entry barriers in certain markets. Thus, while global demand is on the rise, manufacturers and marketers must adopt region-specific strategies to navigate the diverse regulatory and cultural landscape effectively.

What Factors Are Accelerating the Expansion of the Dipotassium Glycyrrhizinate Market?

The growth in the Dipotassium Glycyrrhizinate market is driven by several factors that span technological innovation, consumer trends, and end-use diversification. One of the primary growth drivers is the increasing demand for skin-friendly and anti-inflammatory ingredients in cosmetics, which has led manufacturers to seek out effective botanical alternatives like Dipotassium Glycyrrhizinate. The compound's multifunctionality offering whitening, anti-irritant, antimicrobial, and moisturizing effects makes it a highly efficient ingredient for both high-end and mass-market personal care products. Another major factor is the exponential rise in atopic skin conditions and consumer sensitivity to conventional skincare ingredients, which has made Dipotassium Glycyrrhizinate an appealing substitute in dermatological treatments. The rise of natural cosmeceuticals and OTC (over-the-counter) pharma skincare is also fueling growth, as is its utility in oral care where it serves as a non-irritating anti-inflammatory agent in toothpaste and mouth rinses. Technological advancements in extraction and purification have improved the bioavailability and stability of the compound in complex formulations, further expanding its utility. Additionally, the integration of Dipotassium Glycyrrhizinate in men's grooming, baby care, and anti-aging segments has broadened its application spectrum. On the supply side, increased licorice cultivation in China and Central Asia ensures steady raw material availability, supporting market scalability. Lastly, as brands compete to offer more ethical and eco-friendly products, the compound's plant origin, biodegradable profile, and compatibility with vegan and cruelty-free standards are proving to be powerful drivers of adoption across global markets.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the High Purity segment, which is expected to reach US$30.9 Million by 2030 with a CAGR of a 3.5%. The Low Purity segment is also set to grow at 5.9% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, valued at $10.7 Million in 2024, and China, forecasted to grow at an impressive 6.9% CAGR to reach $9.8 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Dipotassium Glycyrrhizinate Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Dipotassium Glycyrrhizinate Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Dipotassium Glycyrrhizinate Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Alps Pharmaceutical Ind. Co., Ltd., Ambe Phytoextracts Pvt. Ltd., Chengdu Biopurify Phytochemicals Ltd., Chengdu Chenlv Biological Technology, and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 44 companies featured in this Dipotassium Glycyrrhizinate market report include:

• Alps Pharmaceutical Ind. Co., Ltd.
• Ambe Phytoextracts Pvt. Ltd.
• Chengdu Biopurify Phytochemicals Ltd.
• Chengdu Chenlv Biological Technology
• ELION Group
• FAME Pharmaceuticals Industry
• Fanzhi Pharmaceutical Co., Ltd.
• GfN Selco GmbH
• Hunan Dinuo Pharmaceutical Co., Ltd.
• Inga Pharmaceuticals
• Jiangsu Tiansheng Pharmaceutical Co., Ltd.
• Minophagen Pharmaceutical Co., Ltd.
• Nikko Chemicals Co., Ltd.
• Qingdao Taidong Pharmaceutical Co., Ltd.
• Ruihong Bio-technique Co., Ltd.
• Shaanxi Fujie Pharmaceutical Co., Ltd.
• Shaanxi Jintai Biological Engineering Co., Ltd.
• The Actives Factory Ltd.
• VITAL-CHEM Zhuhai Co., Ltd.
• Xi'an Lyphar Biotech Co., Ltd.

This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:

• Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
• Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
• Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
• Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
• Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
• Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
• Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.